1. Home
  2. IOVA vs TENB Comparison

IOVA vs TENB Comparison

Compare IOVA & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.09

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Tenable Holdings Inc.

TENB

Tenable Holdings Inc.

HOLD

Current Price

$25.56

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
TENB
Founded
2007
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
IOVA
TENB
Price
$4.09
$25.56
Analyst Decision
Buy
Buy
Analyst Count
10
18
Target Price
$9.00
$31.69
AVG Volume (30 Days)
13.1M
3.6M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
14.84
3.23
EPS
N/A
0.01
Revenue
N/A
$999,405,000.00
Revenue This Year
$47.74
$9.37
Revenue Next Year
$40.31
$7.04
P/E Ratio
N/A
$2,508.50
Revenue Growth
N/A
11.04
52 Week Low
$1.67
$15.73
52 Week High
$5.63
$35.69

Technical Indicators

Market Signals
Indicator
IOVA
TENB
Relative Strength Index (RSI) 61.90 73.93
Support Level $2.05 $22.03
Resistance Level $4.27 $30.79
Average True Range (ATR) 0.27 1.24
MACD 0.03 0.44
Stochastic Oscillator 87.50 88.69

Price Performance

Historical Comparison
IOVA
TENB

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Share on Social Networks: